Archive > Volume 31 Issue 2 > 2024,31(2):175-182. DOI:10.3872/j.issn.1007-385X.2024.02.009 Prev Next

Review

Research progress in anti-tumor drugs targeting PIK3CA mutations

您是第位访问者
Chinese Journal Of Cancer Biotheray ® 2025 All Rights Reserved
Supported by:Beijing E-Tiller Technology Development Co., Ltd.